Galactokinase Deficiency Clinical Presentation
- Author: Karl S Roth, MD; Chief Editor: Bruce Buehler, MD more...
History
- Hepatosplenomegaly at birth (reported in a single case) is not common in neonates with galactokinase deficiency.
- Failure to develop a social smile or to follow objects may represent initial signs of a visual deficit due to cataracts.
- GI symptoms associated with the ingestion of galactose are conspicuously absent.
- Growth parameters are unaffected.
- Family history is not relevant.
- Soy formula (given to the infant for other reasons) may curtail the development of cataracts and delay the consequent diagnosis of galactokinase deficiency. However, milk products introduced into the diet later will result in cataract formation.
Physical
- Cataracts may be apparent upon gross inspection of the eye.
- Opacities may be visualized during attempts at funduscopic examination.
- Vision-based developmental landmarks, such as tracking, reaching, and social smiling, may be reached late or not at all.
Causes
- Galactokinase deficiency is an autosomal recessive genetic disorder mapped to band 17q24.
- At least 20 mutations are known, of which the P28T mutation is considered the founder mutation.
- Many genetic variations of GALK1 have been identified in the patients with galactokinase deficiency.[4, 5]
Cuthbert C, Klapper H, Elsas L. Diagnosis of inherited disorders of galactose metabolism. Curr Protoc Hum Genet. Jan 2008;Chapter 17:Unit 17.5. [Medline].
Janzen N, Illsinger S, Meyer U, Shin YS, Sander J, Lücke T, et al. Early cataract formation due to galactokinase deficiency: impact of newborn screening. Arch Med Res. Oct 2011;42(7):608-12. [Medline].
Hennermann JB, Schadewaldt P, Vetter B, Shin YS, Mönch E, Klein J. Features and outcome of galactokinase deficiency in children diagnosed by newborn screening. J Inherit Metab Dis. Apr 2011;34(2):399-407. [Medline].
Park HD, Kim YK, Park KU, Kim JQ, Song YH, Song J. A novel c.-22T>C mutation in GALK1 promoter is associated with elevated galactokinase phenotype. BMC Med Genet. Mar 24 2009;10:29. [Medline].
Park HD, Bang YL, Park KU, Kim JQ, Jeong BH, Kim YS, et al. Molecular and biochemical characterization of the GALK1 gene in Korean patients with galactokinase deficiency. Mol Genet Metab. Jul 2007;91(3):234-8. [Medline].
Berry GT. The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr. 1995;154(7 Suppl 2):S53-64. [Medline].
Beutler E, Matsumoto F, Kuhl W, Krill A, Levy N, Sparkes R, et al. Galactokinase deficiency as a cause of cataracts. N Engl J Med. Jun 7 1973;288(23):1203-6. [Medline].
Bosch AM, Bakker HD, van Gennip AH, van Kempen JV, Wanders RJ, Wijburg FA. Clinical features of galactokinase deficiency: a review of the literature. J Inherit Metab Dis. Dec 2002;25(8):629-34. [Medline].
Gitzelmann R. Hereditary galactokinase deficiency, a newly recognized cause of juvenile cataracts. Pediatr Res. 1967;1:14-23.
Hunter M, Heyer E, Austerlitz F. The P28T mutation in the GALK1 gene accounts for galactokinase deficiency in Roma(Gypsy) patients across Europe. Pediatr Res. 2002;51:602-606.
Kerr MM, Logan RW, Cant JS, Hutchison JH. Galactokinase deficiency in a newborn infant. Arch Dis Child. Dec 1971;46(250):864-6. [Medline].
Levy NS, Krill AE, Beutler E. Galactokinase deficiency and cataracts. Am J Ophthalmol. Jul 1972;74(1):41-8. [Medline].
Pickering WR, Howell RR. Galactokinase deficiency: clinical and biochemical findings in a new kindred. J Pediatr. Jul 1972;81(1):50-5. [Medline].
Reich S, Hennerman J, Vetter B. An unexpectedly high frequency of hypergalactosemia in an immigrant Bosnian population revealed by newborn screening. Pediatr Res. 2002;51:598-601.
Sangiuolo F, Magnani M, Stambolian D. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency. Hum Mutat. 2004;23:396.
Thalhammer O, Gitzelmann R, Pantlitschko M. Hypergalactosemia and galactosuria due to galactokinase deficiency in a newborn. Pediatrics. Sep 1968;42(3):441-5. [Medline].

